SFTS-CVM (n = 40) | SFTS-SVM (n = 39) | P-value | |
---|---|---|---|
Electrocardiogram | |||
No Abnormality | 10 (25.00%) | 1 (2.56%) | 0.004** |
Ventricular Premature Beats | 1 (2.50%) | 2 (5.13%) | 0.15 |
Ventricular Tachycardia | 1 (2.50%) | 4 (10.26%) | 0.16 |
Atrial Premature Beats | 6 (15.00%) | 5 (12.82%) | 0.78 |
Atrial Tachycardia | 2 (5.00%) | 4 (10.26%) | 0.38 |
Ventricular Fibrillation | 0 (0.00%) | 3 (7.69%) | 0.07 |
Atrial Fibrillation | 0 (0.00%) | 10 (25.64%) | 0.001** |
Conduction Block | 6 (15.00%) | 6 (15.38%) | 0.96 |
ST-T Segment Changes | 23 (57.50%) | 25 (64.10%) | 0.54 |
ST Segment Elevation Similar to Myocardial Infarction | 0 (0.00%) | 1 (2.56%) | 0.31 |
Abnormal Q Waves | 0 (0.00%) | 4 (10.26%) | 0.39 |
Low Voltage | 0 (0.00%) | 4 (10.26%) | 0.39 |
Bradycardia | 5 (12.50%) | 3 (7.69%) | 0.48 |
Prolonged QT Interval | 3 (7.50%) | 3 (7.69%) | 0.97 |
EchocardiographyΔ | |||
No Abnormality | 1 (2.56%) | 4 (10.26%) | 0.35 |
Ventricular Hypertrophy | 2 (5.13%) | 3 (7.69%) | 0.96 |
Reduced Systolic Function | 1 (2.56%) | 3 (7.69%) | 0.55 |
Reduced Diastolic Function | 1 (2.56%) | 3 (7.69%) | 0.55 |
Cardiac Chamber Enlargement | 6 (15.38%) | 8 (20.51%) | 0.7 |
Valve Regurgitation and Insufficiency | 11 (28.21%) | 14 (35.90%) | 0.34 |
Pericardial Effusion | 0 (0.00%) | 4 (10.26%) | 0.09 |